Condition

Breast Ductal Carcinoma In Situ (2)

Invasive Breast Carcinoma (2)

Multicentric Breast Carcinoma (2)

Anatomic Stage 0 Breast Cancer AJCC v8 (1)

Bilateral Breast Carcinoma (1)

Multifocal Breast Carcinoma (1)

Prognostic Stage 0 Breast Cancer AJCC v8 (1)

Synchronous Bilateral Breast Carcinoma (1)

Overall Status

Active, not recruiting (1)

Recruiting (1)

Sign in for free

Phase

phase 2 (1)

phase 3 (1)

Sponsor

National Cancer Institute (NCI) (1)

Northwestern University (1)

Collaborator

National Cancer Institute (NCI) (1)

Intervention

anastrozole (1)

exemestane (1)

intraoperative imaging (1)

laboratory biomarker analysis (1)

letrozole (1)

lumpectomy (1)

quality-of-life assessment (1)

systemic chemotherapy (1)

tamoxifen citrate (1)

Study Documents

Intervention Type

device (1)

drug (1)

other (1)

procedure (1)

Funder Type

NIH (1)

Other (1)

Study Type

Interventional (2)

multicentric breast carcinoma

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Breast Ductal Carcinoma In Situ, Invasive Breast Carcinoma, Multicentric Breast Carcinoma Trial in Worldwide (Anastrozole,

Active, not recruiting

Breast Ductal Carcinoma In Situ
+4 more

Anastrozole
+6 more

Anniston, Alabama
+1582 more

Jan 28, 2023

Anatomic Stage 0 Breast Cancer AJCC v8, Bilateral Breast Carcinoma, Breast Ductal Carcinoma In Situ Trial in Chicago

Recruiting

Anatomic Stage 0 Breast Cancer AJCC v8
+5 more

Intraoperative Imaging
Lumpectomy

Chicago, Illinois
+3 more

Nov 30, 2022